KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Short term Debt (2016 - 2022)

Historic Short term Debt for Charles River Laboratories International (CRL) over the last 14 years, with Q3 2022 value amounting to $2.1 million.

  • Charles River Laboratories International's Short term Debt fell 861.54% to $2.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.1 million, marking a year-over-year decrease of 861.54%. This contributed to the annual value of $2.8 million for FY2021, which is 9443.38% down from last year.
  • Per Charles River Laboratories International's latest filing, its Short term Debt stood at $2.1 million for Q3 2022, which was down 861.54% from $2.4 million recorded in Q2 2022.
  • Over the past 5 years, Charles River Laboratories International's Short term Debt peaked at $53.7 million during Q2 2020, and registered a low of $2.1 million during Q3 2022.
  • Over the past 5 years, Charles River Laboratories International's median Short term Debt value was $31.3 million (recorded in 2018), while the average stood at $23.8 million.
  • In the last 5 years, Charles River Laboratories International's Short term Debt soared by 87720.75% in 2019 and then crashed by 9525.51% in 2021.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Short term Debt stood at $31.4 million in 2018, then grew by 22.69% to $38.5 million in 2019, then soared by 30.27% to $50.2 million in 2020, then plummeted by 94.43% to $2.8 million in 2021, then decreased by 25.62% to $2.1 million in 2022.
  • Its Short term Debt was $2.1 million in Q3 2022, compared to $2.4 million in Q2 2022 and $2.6 million in Q1 2022.